http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2133690-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87e0ce12f4dfcf1e776190ac96e32e22 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0017 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 |
| filingDate | 1984-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8afbfa9afdcfb7fa2e8b8af3e81a0a9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa6fd2b72d602b5de3259664f533ae67 |
| publicationDate | 1984-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-2133690-A |
| titleOfInvention | Percutaneous levamisole compositions |
| abstract | Levamisole formulations for treating infection by helminthic parasites by application to the skin of the infected animal to provide localised percutaneous absorption comprise 2-20% levamisole in a solvent comprising a monoterpene fraction, particularly terpinolene, or a mixture of alkylbenzenes higher than xylene. The solvent may include a bland non-irritant diluent, e.g. dimethlsulphoxide. The solvent effects transmission of the levamisole through the skin of the animal to give a systemic internal action. The composition may contain additional active ingredients such as anthelmintic pyrethroids and phenylbutazone as a local anti- inflammatory agent. |
| priorityDate | 1983-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.